drugset / Trial / NCT00673621
A Study Designed to Determine if the Pharmacokinetic Disposition of Inhaled Insulin Exposure is the Same for Asthmatics and Non-asthmatics
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will compare the rate and extent of absorption of TI Inhalation Powder in subjects with asthma and subjects with normal lung function. 24 eligible subjects will be enrolled into the treatment phase of the trial.
Timeline
- Start
- 2008-05
- Primary completion
- 2008-11
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | 15 iu | Inhaled |
| Subject | Insulin | Protein / enzyme biologic | 30 iu | Inhaled |
| Subject | Insulin | Protein / enzyme biologic | 45 iu | Inhaled |
| Background | Salbutamol | Unknown | 200 ug | Inhaled |